Mycobacterium
tuberculosis encodes only a single
type II topoisomerase, gyrase. As a result, this enzyme likely carries
out the cellular functions normally performed by canonical gyrase
and topoisomerase IV, both in front of and behind the replication
fork. In addition, it is the sole target for quinolone antibacterials
in this species. Because quinolone-induced DNA strand breaks generated
on positively supercoiled DNA ahead of replication forks and transcription
complexes are most likely to result in permanent genomic damage, the
actions of M. tuberculosis gyrase on positively supercoiled
DNA were investigated. Results indicate that the enzyme acts rapidly
on overwound DNA and removes positive supercoils much faster than
it introduces negative supercoils into relaxed DNA. Canonical gyrase
and topoisomerase IV distinguish supercoil handedness differently
during the DNA cleavage reaction: while gyrase maintains lower levels
of cleavage complexes on overwound DNA, topoisomerase IV maintains
similar levels of cleavage complexes on both over- and underwound
substrates. M. tuberculosis gyrase maintained lower
levels of cleavage complexes on positively supercoiled DNA in the
absence and presence of quinolone-based drugs. By retaining this important
feature of canonical gyrase, the dual function M. tuberculosis type II enzyme remains a safe enzyme to act in front of replication
forks and transcription complexes. Finally, the N-terminal gate region
of the enzyme appears to be necessary to distinguish supercoil handedness
during DNA cleavage, suggesting that the capture of the transport
segment may influence how gyrase maintains cleavage complexes on substrates
with different topological states.